$Recursion Pharmaceuticals(RXRX.US) The medicine must not stop. Add another 10,000 shares
Arcus Biosciences (RCUS)
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. The company’s developmen...
- Open
- 29.880
- High
- 30.390
- Low
- 28.940
- Prev. Close
- 30.350
- Volume
- 1.55M
- Turnover
- 45.85M
- Avg Price
- 29.655
- Bid/Ask Ratio
- --
- Amplitude
- 4.78%
- 52wk High
- 31.735
- Volume Ratio
- 1.32
- Turnover Ratio
- 1.82%
Arcus Biosciences Analyst Rating
View moreForecast & Rating
Aug 17, 2026Price forecast
$38.3329.86%
Forecast & RatingStrong buy
13analysts
- Strong buy76.92%
- Buy0.00%
- Hold23.08%
- Sell0.00%
- Strong sell0.00%
News
- Simplywall · 8 hours ago
Arcus Biosciences (RCUS) Stock Looks Strong On Returns But Stretched On Sales
- PR Newswire · 1 day ago, 06:58 PM
Kuehn Law Encourages Investors of Arcus Biosciences, Inc. to Contact Law Firm
- TradingView · Aug 14 at 02:20 AM
Arcus Biosciences, Inc. Stock 12‑Month Price Target Raised to $38.82, Implies 35% Upside
- Simplywall · Aug 13 at 10:34 AM
Arcus Biosciences (RCUS) Reported Q2 2026 Results, Is The Stock A Bargain?
- PUBT · Aug 11 at 03:35 PM
Arcus Biosciences memberi hibah induksi: opsi 2.850 saham dan 1.450 RSU untuk karyawan baru
- Market Beat · Aug 6 at 12:54 PM
Arcus Biosciences (NYSE:RCUS) Price Target Raised to $26.00